YI vs. PETS, CJJD, CVS, WBA, ALLO, LXRX, TBPH, OCGN, BTMD, and FBLG
Should you be buying 111 stock or one of its competitors? The main competitors of 111 include PetMed Express (PETS), China Jo-Jo Drugstores (CJJD), CVS Health (CVS), Walgreens Boots Alliance (WBA), Allogene Therapeutics (ALLO), Lexicon Pharmaceuticals (LXRX), Theravance Biopharma (TBPH), Ocugen (OCGN), biote (BTMD), and FibroBiologics (FBLG).
111 (NASDAQ:YI) and PetMed Express (NASDAQ:PETS) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, community ranking, institutional ownership, analyst recommendations, risk, profitability and earnings.
PetMed Express has lower revenue, but higher earnings than 111. PetMed Express is trading at a lower price-to-earnings ratio than 111, indicating that it is currently the more affordable of the two stocks.
In the previous week, 111 had 8 more articles in the media than PetMed Express. MarketBeat recorded 14 mentions for 111 and 6 mentions for PetMed Express. PetMed Express' average media sentiment score of 0.86 beat 111's score of 0.24 indicating that PetMed Express is being referred to more favorably in the news media.
PetMed Express received 23 more outperform votes than 111 when rated by MarketBeat users. However, 61.69% of users gave 111 an outperform vote while only 45.13% of users gave PetMed Express an outperform vote.
21.3% of 111 shares are owned by institutional investors. Comparatively, 73.3% of PetMed Express shares are owned by institutional investors. 43.9% of 111 shares are owned by insiders. Comparatively, 3.6% of PetMed Express shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
111 has a net margin of -2.55% compared to PetMed Express' net margin of -2.92%. 111's return on equity of 0.00% beat PetMed Express' return on equity.
PetMed Express has a consensus price target of $6.50, suggesting a potential upside of 60.49%. Given PetMed Express' higher possible upside, analysts clearly believe PetMed Express is more favorable than 111.
111 has a beta of 0.36, meaning that its stock price is 64% less volatile than the S&P 500. Comparatively, PetMed Express has a beta of 0.73, meaning that its stock price is 27% less volatile than the S&P 500.
Summary
PetMed Express beats 111 on 9 of the 16 factors compared between the two stocks.
Get 111 News Delivered to You Automatically
Sign up to receive the latest news and ratings for YI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding YI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Related Companies and Tools